RA
Rosalind Advisors’s Xeris Biopharma Holdings XERS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.1M | Sell |
2,155,594
-340,392
| -14% | -$1.59M | 4.77% | 6 |
|
|
2025
Q1 | $13.7M | Sell |
2,495,986
-609,009
| -20% | -$3.34M | 6.66% | 3 |
|
|
2024
Q4 | $10.5M | Hold |
3,104,995
| – | – | 5.38% | 5 |
|
|
2024
Q3 | $8.85M | Sell |
3,104,995
-15,175
| -0.5% | -$43.2K | 5.67% | 7 |
|
|
2024
Q2 | $7.02M | Buy |
3,120,170
+300,000
| +11% | +$675K | 5.4% | 6 |
|
|
2024
Q1 | $6.23M | Sell |
2,820,170
-723,515
| -20% | -$1.6M | 5.82% | 5 |
|
|
2023
Q4 | $8.33M | Buy |
+3,543,685
| New | +$8.33M | 6.86% | 4 |
|